Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...
FOSTER CITY, Calif. — FOSTER CITY, Calif. — Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $1.78 billion. The Foster City, California-based company said it had net income ...
The company has also announced impending office closures in Seattle and Philadelphia. Gilead revealed the Foster City cuts in a WARN filing on Wednesday, as is generally required by the Worker ...
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
Foster City, California-based Gilead collaborated with the CDC in the mid-2000s to test if Gilead's Truvada could prevent transmission of HIV, the virus that causes AIDS, in addition to treating it.
FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results